Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
5.951 INR | -0,05 % | -1,67 % | +2,64 % |
Resumen de negocios
- ventas de medicamentos genéricos (79,9%): medicamentos con receta de marca o genéricos y medicamentos de venta libre;
- ventas de principios activos (15,7%). El grupo también suministra servicios farmacéuticos personalizados;
- otros (4,4%): ventas de productos biofarmacéuticos genéricos, desarrollo de agentes moleculares, etc.
Las ventas netas se distribuyen geográficamente de la siguiente manera: India (18,8%), Estados Unidos (45%), Rusia (9,9%) y otros (26,3%).
Número de empleados: 25 863
Ventas por actividad
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Global Generics
86,9
%
| 179 170 | 83,6 % | 213 768 | 86,9 % | +19,31 % |
Pharmaceutical Services and Active Ingredients
11,8
%
| 30 740 | 14,3 % | 29 069 | 11,8 % | -5,44 % |
Others
1,2
%
| 2 870 | 1,3 % | 3 042 | 1,2 % | +5,99 % |
Ventas por región
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
43,4
%
| 80 564 | 37,6 % | 106 683 | 43,4 % | +32,42 % |
Others
27,4
%
| 68 962 | 32,2 % | 67 469 | 27,4 % | -2,16 % |
India
20,5
%
| 43 986 | 20,5 % | 50 499 | 20,5 % | +14,81 % |
Russia
8,6
%
| 20 879 | 9,7 % | 21 228 | 8,6 % | +1,67 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 02/04/18 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 02/11/20 |
Chairman | 56 | 18/01/93 | |
Gunupati Prasad
CHM | Chairman | 63 | 08/04/86 |
B. Phanimitra
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/23 |
K. Randhir Singh
CMP | Compliance Officer | - | 17/03/22 |
Archana Bhaskar
IRO | Public Communications Contact | 57 | 01/06/17 |
Amith Agarwal
IRC | Investor Relations Contact | - | - |
Jayanth Sridhar
PRN | Corporate Officer/Principal | - | - |
Vivek Mittal
LAW | General Counsel | - | 01/05/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 08/04/86 |
Chairman | 56 | 18/01/93 | |
Kalpana Morparia
BRD | Director/Board Member | 73 | 05/06/07 |
Shikha Sharma
BRD | Director/Board Member | 64 | 31/01/19 |
Leo Puri
BRD | Director/Board Member | 63 | 25/10/18 |
Claudio Albrecht
BRD | Director/Board Member | - | 10/05/23 |
Arun M. Kumar
BRD | Director/Board Member | 72 | 01/08/22 |
Sanjiv Mehta
BRD | Director/Board Member | 63 | 29/12 |
Director/Board Member | 64 | 07/01/22 | |
Alpna Seth
BRD | Director/Board Member | 60 | 19/09/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 166 874 039 | 152 715 641 ( 91,52 %) | 345 564 ( 0,2071 %) | 91,52 % |
Información de la empresa
Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337 Road No. 3
500034, Hyderabad
+91 40 4900 2900
http://www.drreddys.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Aurigene Discovery Technologies Ltd.
Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. |
Biotechnology
|
Dr. Reddy's Laboratories SA
Dr. Reddy's Laboratories SA Pharmaceuticals: MajorHealth Technology Part of Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories SA is a Swiss company that develops, manufactures and sells pharmaceutical products. The private company is based in Basel, Switzerland. |
Pharmaceuticals: Major
|
Aurigene Pharmaceutical Services Ltd.
Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Aurigene Pharmaceutical Services Ltd. is a contract research, development, and manufacturing organization. It offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development, and manufacturing for clinical phase I-III programs. The company is headquartered in Bangalore, India. |
Biotechnology
|
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,64 % | 11,9 mil M | |
+25,50 % | 672 mil M | |
+25,87 % | 570 mil M | |
-5,27 % | 360 mil M | |
+16,69 % | 321 mil M | |
+8,30 % | 300 mil M | |
+7,09 % | 217 mil M | |
-9,12 % | 204 mil M | |
+5,01 % | 199 mil M | |
-8,74 % | 149 mil M |
- Bolsa de valores
- Acciones
- Acción DRREDDY
- Empresa Dr. Reddy's Laboratories Limited